Natural Product: NPC159577

Natural Product IDNPC159577
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(2R)-6-Methyl-5-Methylideneheptan-2-Yl]-1,2,6,7,8,9,11,12,14,15,16,17-Dodecahydrocyclopenta[A]Phenanthren-3-One
IUPAC Name (8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL2322191
PubChem CID 14753570
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0003567] Ergostane steroids
          • [CHEMONTID:0001403] Ergosterols and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey JRMPVNVOLQJLJX-QVMRCSLBSA-N
Standard InCHI InChI=1S/C28H44O/c1-18(2)19(3)7-8-20(4)24-11-12-25-23-10-9-21-17-22(29)13-15-27(21,5)26(23)14-16-28(24,25)6/h17-18,20,23-26H,3,7-16H2,1-2,4-6H3/t20-,23+,24-,25+,26+,27+,28-/m1/s1
SMILES CC(C)C(=C)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   396.34 Volume:   459.499
?
Van der Waals volume.
Dense:   0.863 LogP:   6.646
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.615
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -6.784
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   5.0 Rigid Bonds:   22.0
TPSA:   17.07
?
Topological Polar Surface Area.
H-Bond Acceptor:   1.0
H-Bond Donor:   0.0 Rings:   4.0
Heavy Atoms:   1.0

MedChem Properties

QED Drug-Likeness Score:   0.434 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.265 Fsp3:   0.821
MCE-18:   68.824
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.851 Fluc inhibitor:   0.002
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.005
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.723 Promiscuous compounds:   0.173

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.771 MDCK Permeability:   -4.886
Pgp-inhibitor:   0.682 Pgp-substrate:   0.0
PAMPA:   0.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.032 30% Bioavailability (F30%):   0.47
50% Bioavailability (F50%):   0.974

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.152 MRP1:   0.141
Plasma Protein Binding (PPB):   97.403% Volume Distribution (VD):   0.009
Fu: 2.658%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.629
BSEP inhibitor:   0.976

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.999
CYP2C19-inhibitor:   1.0 CYP2C19-substrate:   0.316
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.117
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.961
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.969
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  11.359 Half-life (T1/2):  0.253

ADMET: Toxicity

hERG Blockers:  0.141 hERG Blockers (10um):  0.549
Human Hepatotoxicity (H-HT):  0.686 Drug-induced Liver Injury (DILI):  0.266
AMES Toxicity:  0.164 Rat Oral Acute Toxicity:  0.228
Maximum Recommended Daily Dose:  0.49 Skin Sensitization:  0.872
Carcinogencity:  0.791 Eye Corrosion:  0.484
Eye Irritation:  0.946 Respiratory Toxicity:  0.731
Drug-induced Neurotoxicity:  0.389 Ototoxicity:  0.423
Hematotoxicity:  0.588 Drug-induced Nephrotoxicity:  0.357
Genotoxicity:  0.434 RPMI-8226 Immunitoxicity:  0.05
A549 Cytotoxicity:  0.092 Hek293 Cytotoxicity:  0.356
BCF:   3.004
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.772
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.465
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.602
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO17094 Sinularia depressa Species Alcyoniidae Eukaryota n.a. n.a. n.a. PMID[20121250]
NPO13364 Caloncoba glauca Species Achariaceae Eukaryota leaves n.a. n.a. PMID[22360639]
NPO17094 Sinularia depressa Species Alcyoniidae Eukaryota n.a. Hainan soft coral n.a. PMID[23357636]
NPO13364 Caloncoba glauca Species Achariaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO9161 Celastrus pringlei Species Celastraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO17094 Sinularia depressa Species Alcyoniidae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO11120.1 Brassica rapa subsp. chinensis Subspecies Brassicaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO11120.1 Brassica rapa subsp. chinensis Subspecies Brassicaceae Eukaryota n.a. n.a. Database[FooDB]
NPO11120.1 Brassica rapa subsp. chinensis Subspecies Brassicaceae Eukaryota n.a. n.a. Database[Phenol-Explorer]
NPO11120.1 Brassica rapa subsp. chinensis Subspecies Brassicaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO9161 Celastrus pringlei Species Celastraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO7102 Reniera sarai n.a. n.a. n.a. n.a. n.a. n.a. Database[UNPD]
NPO17094 Sinularia depressa Species Alcyoniidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO11120.1 Brassica rapa subsp. chinensis Subspecies Brassicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO14764 Ehretia laevis Species Ehretiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO16004 Phyllotopsis nidulans Species Lentinaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO15821 Apis dorsata Species Apidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13364 Caloncoba glauca Species Achariaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13496 Mentzelia lindleyi Species Loasaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT178 Individual protein Protein-tyrosine phosphatase 1B Homo sapiens IC50 = 15300.0 nM PMID[23357636]
NPT78 Individual protein Beta amyloid A4 protein Homo sapiens Activity = 16.6 % PMID[23357636]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 16.9 % PMID[23357636]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC159577 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8913 High Similarity NPC282593
0.7959 Intermediate Similarity NPC35734
0.7959 Intermediate Similarity NPC602429
0.78 Intermediate Similarity NPC149203
0.7143 Intermediate Similarity NPC307176
0.7143 Intermediate Similarity NPC321874
0.6964 Remote Similarity NPC320514
0.6923 Remote Similarity NPC115023
0.6731 Remote Similarity NPC214043
0.6731 Remote Similarity NPC85774
0.6667 Remote Similarity NPC303613
0.6667 Remote Similarity NPC249312
0.6481 Remote Similarity NPC237712
0.6207 Remote Similarity NPC309603
0.5962 Remote Similarity NPC139397
0.5862 Remote Similarity NPC469948
0.5741 Remote Similarity NPC2634
0.5741 Remote Similarity NPC265782
0.5741 Remote Similarity NPC251929
0.5614 Remote Similarity NPC251705
0.5536 Remote Similarity NPC255021
0.5536 Remote Similarity NPC227064
0.5536 Remote Similarity NPC474228
0.5536 Remote Similarity NPC329043
0.5536 Remote Similarity NPC58841
0.5536 Remote Similarity NPC161423
0.5517 Remote Similarity NPC323765
0.5439 Remote Similarity NPC144258
0.5439 Remote Similarity NPC327115
0.5385 Remote Similarity NPC187159
0.5238 Remote Similarity NPC305039
0.5167 Remote Similarity NPC310010
0.5167 Remote Similarity NPC326627
0.5085 Remote Similarity NPC328539
0.5082 Remote Similarity NPC473999
0.5079 Remote Similarity NPC489872

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC159577 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7143 Intermediate Similarity NPD4747 Phase 4
0.614 Remote Similarity NPD5737 Phase 4
0.5965 Remote Similarity NPD6938 Clinical (unspecified phase)
0.5965 Remote Similarity NPD6939 Phase 3
0.5932 Remote Similarity NPD6672 Phase 4
0.5741 Remote Similarity NPD4691 Approved
0.5536 Remote Similarity NPD3666 Phase 4
0.5536 Remote Similarity NPD4221 Phase 4
0.55 Remote Similarity NPD6409 Approved
0.5424 Remote Similarity NPD5330 Phase 4
0.5254 Remote Similarity NPD4693 Phase 3
0.5238 Remote Similarity NPD6904 Phase 4
0.5167 Remote Similarity NPD4753 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data